It is also emphasized that glutamine metabolism heterogeneity and adaptability become one of the main reasons for drug resistance in tumor patients, so we explore the mechanism of cancer cells utilizing glutamine metabolism-related branched pathways as well as bypassing glutamine metabolism to participate in the occurrence of drug resistance, which provides a new diagnostic and therapeutic idea for the further clinical development of glutamine metabolism-related antitumor drugs
Can Glutaban-IV be mixed with other IV solutions
Investigating a signature of Temozolomide resistance in GBM cell lines using metabolomics
Cyanocobalamin (Vitamin B12) 5000 mcg, Benzyl Alcohol (preservative) 1.0% v/v, Sodium Chloride 0.22% w/v, Ammonium Sulfate 0.1% w/v, Citric Acid 0.01% w/v, Sodium Citrate 0.008% w/v
These observations are corroborated at the molecular level, with dysregulation in the expression of pro-proliferative proteins (e.g., cyclin D1) and tight junction proteins (e.g., zonula occludens-1, occludin, and claudin 1, 4, and 8) (Birder, 2019)
Development of a new treatment for Alzheimers disease and Parkinsons disease using anti-inflammatory and neurotrophic compounds
